The Role of Ticagrelor in STEMI Fibrinolytic and Its Rationale to Utilize for Indonesian Patients
Worldwide, ischemic heart disease is the most common cause of death and its frequency is increasing. ST-segment elevation myocardial infarction or STEMIis as form of ischemic heart disease with the highest mortality rate. Based on ESC (European Society of Cardiology) guideline 2017 for STEMI man...
Main Authors: | Daniel Tobing, Dafsah Juzar, Achmad Fauzi Yahya, Antonia Anna Lukito, Doni Firman, Sodiqur Rifqi, Abdul Hakim Alkatiri, Rurus Suryawan |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2019-09-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | http://ijconline.id/index.php/ijc/article/view/915 |
Similar Items
-
Assessment of myocardial salvage in patients with STEMI undergoing thrombolysis: ticagrelor versus clopidogrel
by: Anastasiou, I., et al.
Published: (2022) -
Does the level of myocardial injury differ in primary angioplasty patients loaded first with clopidogrel and the ones with ticagrelor?
by: Nil Ozyuncu, et al.
Published: (2020-07-01) -
Tantangan Penatalaksanaan STEMI di Pandemi Covid-19
by: Sunanto Ng, et al.
Published: (2020-05-01) -
Risk definition and outcomes with the application of the PEGASUS-TIMI 54 trial inclusion criteria to a “real world” STEMI population: results from the Italian “CARDIO-STEMI SANREMO” registry
by: Federico Sanchez, et al.
Published: (2021-03-01) -
Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry
by: Himawan Fernando, et al.
Published: (2021-04-01)